ELV392.73-0.47%
ELV · US
1y range: 280.74 → 426.79 · as of 2026-09-29
AI digest — today
Elevance Health staat onder druk na lagere earnings- en revenue-forecasts van analisten ($6.18 EPS verwacht), ondanks een sterke koersperformance van +33,61% over 90 dagen. Tegelijkertijd vecht het bedrijf een rechtszaak uit tegen HHS/CMS over Medicare Star Ratings die naar eigen zeggen $115 miljoen aan bonusbetalingen hebben gekost.
Generated 2026-07-11 06:00
Recent material news
- Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation2026-09-10T14:13
- Elevance Health Affirms FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est2026-09-10T06:28
- Elevance Health Affirms FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est2026-09-10T06:28
- Can Centene's Marketplace Recovery Fuel Stronger Earnings Growth?2026-09-01T15:54
- Freenome shares are trading higher after the company announced FDA approval for its SimpleSreen CRC blood-based screening test.2026-09-01T11:52
Want this depth on every stock you watch?
ThickerPeek writes a daily AI digest on 165+ stocks, weekly theses, earnings briefings, and alerts — for €19/mo. Free tier available.
Not investment advice. ThickerPeek is a research tool. AI-written content is informational, not a buy/sell recommendation. Investment decisions are your own responsibility.